Figure 2.
Correlation between CSF and serum levels of sICAM‐1, sVCAM‐1 and sL‐selectin levels in anti‐NMDAR encephalitis patients (A–C) (Spearman test).
Correlation between CSF and serum levels of sICAM‐1, sVCAM‐1 and sL‐selectin levels in anti‐NMDAR encephalitis patients (A–C) (Spearman test).